Secondary Research – Potential Growing Markets

Transparency Market Research (TMR) estimates that global urinary drainage catheter market sales in 2016 to have been approximately $3 billion and expected this to expand at a steady CAGR of above 5% over the forecast period from 2017 to 2025 to reach a sales value of around $5 billion in 2025. [8] Of course, that is only the urinary drainage catheter market, and UroPharma will also derive significant revenue from the drugs that will be sold in combination with the dtb-instilla.

According to research carried out in 2018 by Cleveland Clinic (a reputable non-profit academic medical center), there is an estimated 2.5 million people with Multiple Sclerosis (MS) worldwide and 1 million in the US alone; [6] although this US estimate is substantially higher than others.

 

We have based our market projections on an estimated of 400,000 people with MS in North America. [9] Additionally, the Multiple Sclerosis International Federation (MSIF) estimates that 10,000 new cases are diagnosed every year in the US (that’s 200 new cases per week). [7] Of all those people, it is anticipated that up to 90% will experience bladder problems. [1]

Contact Us

Tel: +44 (0) 1603 626 960

Email: info@uropharma.com

Social Media

  • LinkedIn Social Icon

Linkedin.com/company/uropharma

  • Twitter

Twitter.com/UroPharma

  • Facebook

Facebook.com/bladdercontrol

©2017-2020 UroPharma, Inc. All Rights Reserved